These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9248601)

  • 1. Pharmacist influence on economic and morbidity outcomes in a tertiary care teaching hospital.
    Boyko WL; Yurkowski PJ; Ivey MF; Armitstead JA; Roberts BL
    Am J Health Syst Pharm; 1997 Jul; 54(14):1591-5. PubMed ID: 9248601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of pharmacist participation on a medical team on costs, charges, and length of stay.
    Haig GM; Kiser LA
    Am J Hosp Pharm; 1991 Jul; 48(7):1457-62. PubMed ID: 1882873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A prospective multicentre study of pharmacist initiated changes to drug therapy and patient management in acute care government funded hospitals.
    Dooley MJ; Allen KM; Doecke CJ; Galbraith KJ; Taylor GR; Bright J; Carey DL
    Br J Clin Pharmacol; 2004 Apr; 57(4):513-21. PubMed ID: 15025751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of clinical pharmacist engagement in ward teams on the number of drug-related readmissions among older patients with dementia or cognitive impairment: An economic evaluation.
    Sjölander M; Lindholm L; Pfister B; Jonsson J; Schneede J; Lövheim H; Gustafsson M
    Res Social Adm Pharm; 2019 Mar; 15(3):287-291. PubMed ID: 29778344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interrelationships among mortality rates, drug costs, total cost of care, and length of stay in United States hospitals: summary and recommendations for clinical pharmacy services and staffing.
    Bond CA; Raehl CL; Franke T
    Pharmacotherapy; 2001 Feb; 21(2):129-41. PubMed ID: 11213848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of pharmacist interventions on rational prophylactic antibiotic use and cost saving in elective cesarean section.
    Wang J; Dong M; Lu Y; Zhao X; Li X; Wen A
    Int J Clin Pharmacol Ther; 2015 Aug; 53(8):605-15. PubMed ID: 26104036
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic consequences of two drug-use control systems in a teaching hospital.
    Clapham CE; Hepler CD; Reinders TP; Lehman ME; Pesko L
    Am J Hosp Pharm; 1988 Nov; 45(11):2329-40. PubMed ID: 3228089
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of clinical pharmacist's interventions in an infectious diseases ward and impact on patient's direct medication cost.
    Khalili H; Karimzadeh I; Mirzabeigi P; Dashti-Khavidaki S
    Eur J Intern Med; 2013 Apr; 24(3):227-33. PubMed ID: 23245928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cost-benefit analysis of twice-daily consultant ward rounds and clinical input on investigation and pharmacy costs in a major teaching hospital in the UK.
    Ahmad A; Weston PJ; Ahmad M; Sharma D; Purewal T
    BMJ Open; 2015 Apr; 5(4):e007367. PubMed ID: 25854972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of a pharmacy resident on hospital length of stay and drug-related costs.
    Terceros Y; Chahine-Chakhtoura C; Malinowski JE; Rickley WF
    Ann Pharmacother; 2007 May; 41(5):742-8. PubMed ID: 17440008
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of pharmacist participation in intensive care units on clinical and economic outcomes of critically ill patients with thromboembolic or infarction-related events.
    MacLaren R; Bond CA
    Pharmacotherapy; 2009 Jul; 29(7):761-8. PubMed ID: 19558249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical pharmacy services in an Iranian teaching hospital: a descriptive study.
    Dashti-Khavidaki S; Khalili H; Hamishekar H; Shahverdi S
    Pharm World Sci; 2009 Dec; 31(6):696-700. PubMed ID: 19806466
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implementation of a pharmacist-led antimicrobial management team in a community teaching hospital: use of pharmacy residents and pharmacy students in a prospective audit and feedback approach.
    Laible BR; Nazir J; Assimacopoulos AP; Schut J
    J Pharm Pract; 2010 Dec; 23(6):531-5. PubMed ID: 21507858
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimization of inpatient warfarin therapy: impact of daily consultation by a pharmacist-managed anticoagulation service.
    Dager WE; Branch JM; King JH; White RH; Quan RS; Musallam NA; Albertson TE
    Ann Pharmacother; 2000 May; 34(5):567-72. PubMed ID: 10852081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the clinical pharmacist in reducing mortality in hospitalized cardiac patients: A prospective, nonrandomized controlled trial using propensity score methods.
    Zhai XB; Tian DD; Liu XY
    Int J Clin Pharmacol Ther; 2015 Mar; 53(3):220-9. PubMed ID: 25546163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implementation and evaluation of a collaborative clinical pharmacist's medications reconciliation and charting service for admitted medical inpatients in a metropolitan hospital.
    Khalil V; deClifford JM; Lam S; Subramaniam A
    J Clin Pharm Ther; 2016 Dec; 41(6):662-666. PubMed ID: 27578624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Description of pharmacist interventions during physician-pharmacist co-management of hypertension.
    Von Muenster SJ; Carter BL; Weber CA; Ernst ME; Milchak JL; Steffensmeier JJ; Xu Y
    Pharm World Sci; 2008 Jan; 30(1):128-35. PubMed ID: 17710561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of a clinical pharmacist on a neurosurgical team.
    Weant KA; Armitstead JA; Ladha AM; Sasaki-Adams D; Hadar EJ; Ewend MG
    Neurosurgery; 2009 Nov; 65(5):946-50; discussion 950-1. PubMed ID: 19834408
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The economic impact of clinical pharmacists' unsolicited recommendations.
    Torok N; Brown G
    Hosp Pharm; 1992 Dec; 27(12):1052-3, 1056-8, 1060. PubMed ID: 10122507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of the impact of a critical care pharmacist assigned as a member of the multidisciplinary burn care team.
    Patel NP; Brandt CP; Yowler CJ
    J Burn Care Res; 2006; 27(3):310-3. PubMed ID: 16679898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.